Identification of amino acids within the P2X2 receptor C‐terminus that regulate desensitization

1 The ATP‐activated P2X2(a) and P2X2(b) receptor splice variants, which differ only in their C‐terminal sequences, desensitize at different rates. We used mutational analysis to investigate the involvement of the C‐terminal region in receptor desensitization. Rat wild‐type and mutant P2X2 receptors were expressed in Xenopus oocytes and currents were measured using the two‐electrode voltage‐clamp technique. 2 Truncating P2X2 at the Lys369 splice site increased the rate of desensitization by >100‐fold. Recovery from desensitization was slowed by ∼5‐fold. 3 Addition of Val370 onto the C‐terminus of the truncated receptor slowed desensitization by ∼70‐fold. Point mutations that substituted either smaller or larger hydrophobic amino acids for Val370, within the P2X2(a) splice variant, had profound effects on the rate of desensitization. The rate decreased with increasing hydrophobicity but was not dependent upon the precise structure of the side group. 4 A mutant receptor, with only nine amino acids, Val‐Asp‐Pro‐Lys‐Gly‐Leu‐Ala‐Gln‐Leu, beyond the Lys369 splice site, desensitized at a similar rate to P2X2(a). Injection of the peptide of this sequence into oocytes expressing P2X2(a) increased the rate of desensitization, whereas the eight‐residue peptide lacking the valine had no effect. 5 Neutralizing lysines in the vicinity of the splice site increased the rate of receptor desensitization. Substituting glutamine for Lys365 produced the greatest effect (∼30‐fold increase), whereas mutating lysines that were further upstream or downstream of this position had progressively less of an effect. 6 We conclude that the C‐terminal splice site of the P2X2 receptor is located within a region that is critically involved in regulating the rate of receptor desensitization. The valine at position 370 interacts with an intracellular hydrophobic site to slow the rate of desensitization. Nearby lysines may facilitate this interaction.

[1]  E. Mccleskey,et al.  A Memory for Extracellular Ca2+ by Speeding Recovery of P2X Receptors from Desensitization , 1998, The Journal of Neuroscience.

[2]  Geoffrey Burnstock,et al.  A P2X purinoceptor cDNA conferring a novel pharmacological profile , 1995, FEBS letters.

[3]  T. Egan,et al.  Co-Expression of P 2 X 1 and P 2 X 5 Receptor Subunits Reveals a Novel ATP-Gated Ion Channel , 1998 .

[4]  E. Mccleskey,et al.  A Memory for Extracellular Ca 2 1 by Speeding Recovery of P 2 X Receptors from Desensitization , 1998 .

[5]  R. Hume,et al.  Two mechanisms for inward rectification of current flow through the purinoceptor P2X2 class of ATP‐gated channels , 1998, The Journal of physiology.

[6]  E A Barnard,et al.  Localization and functional expression of splice variants of the P2X2 receptor. , 1997, Molecular pharmacology.

[7]  P. Seeburg,et al.  Glutamate receptor channels: novel properties and new clones. , 1992, Trends in pharmacological sciences.

[8]  K. Parker Modulation of ATP‐gated non‐selective cation channel (P2X1 receptor) activation and desensitization by the actin cytoskeleton , 1998, The Journal of physiology.

[9]  C. D. Benham,et al.  A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle , 1987, Nature.

[10]  H P Zenner,et al.  Desensitization of the P2X2 receptor controlled by alternative splicing , 1997, FEBS letters.

[11]  G. Burnstock,et al.  Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.

[12]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[13]  P. Séguéla,et al.  Central P 2 X 4 and P 2 X 6 Channel Subunits Coassemble into a Novel Heteromeric ATP Receptor , 1998 .

[14]  P. Séguéla,et al.  Central P2X4 and P2X6 Channel Subunits Coassemble into a Novel Heteromeric ATP Receptor , 1998, The Journal of Neuroscience.

[15]  J. A. Peters,et al.  Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. , 1993, European journal of pharmacology.

[16]  T. Egan,et al.  Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. , 1998, Molecular pharmacology.

[17]  P. Whiting,et al.  Ethanol potentiation of GABAA receptors requires phosphorylation of the alternatively spliced variant of the γ2 subunit , 1992, FEBS letters.

[18]  S. Seino,et al.  Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. , 1996, Biochemical and biophysical research communications.

[19]  R. North,et al.  A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP , 1994, Nature.

[20]  T. Blackburn,et al.  Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytes , 1994, Neuropharmacology.

[21]  D. Julius,et al.  New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor , 1994, Nature.

[22]  W. Stühmer,et al.  P2X4: an ATP-activated ionotropic receptor cloned from rat brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Bean Pharmacology and electrophysiology of ATP-activated ion channels. , 1992, Trends in pharmacological sciences.

[24]  T. Egan,et al.  Hetero-oligomeric Assembly of P2X Receptor Subunits , 1999, The Journal of Biological Chemistry.

[25]  P. Séguéla,et al.  A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  S. Stojilkovic,et al.  Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. , 1998, Molecular endocrinology.

[27]  R. North,et al.  Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). , 1995, Molecular pharmacology.

[28]  R. North,et al.  Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  R. North,et al.  Identification of amino acid residues contributing to the pore of a P2X receptor , 1997, The EMBO journal.

[30]  L. Khiroug,et al.  The effect of the neuropeptide substance P on desensitization of ATP receptors of PC12 cells , 1997, British journal of pharmacology.

[31]  G. Burnstock,et al.  A P2X purinoceptor expressed by a subset of sensory neurons , 1995, Nature.

[32]  M. Bennett,et al.  Alternatively spliced isoforms of the NMDARI receptor subunit , 1995, Trends in Neurosciences.

[33]  Z. Zhou,et al.  Identification of a site that modifies desensitization of P2X2 receptors. , 1998, Biochemical and biophysical research communications.

[34]  R. North,et al.  Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons , 1995, Nature.

[35]  T. Egan,et al.  A Domain Contributing to the Ion Channel of ATP-Gated P2X2 Receptors Identified by the Substituted Cysteine Accessibility Method , 1998, The Journal of Neuroscience.

[36]  Stanko S. Stojilkovic,et al.  Identification of Amino Acid Residues Contributing to Desensitization of the P2X2 Receptor Channel* , 1998, The Journal of Biological Chemistry.

[37]  R. North,et al.  An antagonist‐insensitive P2X receptor expressed in epithelia and brain. , 1996, The EMBO journal.

[38]  R. North,et al.  Domains of P2X receptors involved in desensitization. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Heinemann,et al.  Zinc potentiates agonist-lnduced currents at certain splice variants of the NMDA receptor , 1993, Neuron.